W14-036 : Novel nitro antimicrobial drugs for treatment-refractory feline Tritrichomonas foetus infection, $15,000 (Winn-funded study) Lars Eckmann, MD, Yukiko Miyamoto, DVM, PhD; University of California-San Diego
Tritrichomonas foetus is a parasite affecting cats that may manifest as severe inflammation of the colon with diarrhea. Treatment is difficult as effective drugs are not available for cats. Eradication of the infection is challenging for veterinarians and breeders alike. Different drugs have been tried for the treatment of T. foetus infection, but with only limited success.
The investigators’ proposal for the study was to develop a new and effective drug for treatment. They tested over 600 drug candidates in the laboratory to see if any would be effective in clearing the organism. They found over 50 possible candidates in their experiments on the parasite in culture. Ultimately, they found two new compounds that could reduce infection. Their results provide a strong basis for future commercial development of a new antimicrobial drug for the improved treatment of feline tritrichomoniasis.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
